China's Concord Medical Services H1 net loss narrows

Concord Medical Services Holdings

26/09/2025 12:42

Overview

Concord Medical's H1 2025 revenue falls 8.3% yr/yr to RMB200.6 mln  (US$28.0 million)

Net loss narrows to RMB27.1 mln (US$3.8 million) from RMB172.3 mln last year

Hospital business revenue up 11.1% due to proton therapy operations at Guangzhou Concord Cancer Hospital

Outlook

Company to advance proton therapy and enhance precision radiotherapy understanding

Concord Medical aims to expand access to advanced diagnostic technologies

Company plans to strengthen patient confidence in precision radiotherapy

Concord Medical committed to improving patient access to innovative medications

Result Drivers

PROTON THERAPY - Hospital business revenue increased by 11.1% due to the commencement of proton therapy operations at Guangzhou Concord Cancer Hospital

NETWORK BUSINESS DECLINE - Network business revenue fell 41.3% due to decreased demand for medical equipment and software and non-renewal of expired contracts

COST EFFICIENCY - Gross loss margin improved due to adjustments in revenue structure and strategic focus on enhancing operational efficiency and reducing costs

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
H1 Revenue
RMB 200.60 mln
H1 EPS
RMB 0.21
H1 Net Income
-RMB 27.10 mln
H1 Adjusted EBITDA
-RMB 62.20 mln


Press Release: ID:nPnbGX85Ba

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)